Related Experiment Video
Updated: Apr 28, 2026

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model
Published on: August 4, 2017
Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia
Hyun Joon Paek1, Courtney Kim1, Stuart K Williams1
1Hyun Joon Paek, Courtney Kim, Biologics, Tissue Genesis Institute, LLC, Honolulu, HI 96813, United States.
Abstract:
Diabetes mellitus (diabetes) is a devastating disease that affects millions of people globally and causes a myriad of complications that lead to both patient morbidity and mortality. Currently available therapies, including insulin injection and beta cell replacement through either pancreas or pancreatic islet transplantation, are limited by the availability of organs. Stem cells provide an alternative treatment option for beta cell replacement through selective differentiation of stem cells into cells that recognize glucose and produce and secrete insulin. Embryonic stem cells, albeit pluripotent, face a number of challenges, including ethical and political concerns and potential teratoma formation. Adipose tissue represents an alternative source of multipotent mesenchymal stem cells, which can be obtained using a relatively simple, non-invasive, and inexpensive method. Similarly to other adult mesenchymal stem cells, adipose-derived stem cells (ADSCs) are capable of differentiating into insulin-producing cells. They are also capable of vasculogenesis and angiogenesis, which facilitate engraftment of donor pancreatic islets when co-transplanted. Additionally, anti-inflammatory and immunomodulatory effects of ADSCs can protect donor islets during the early phase of transplantation and subsequently improve engraftment of donor islets into the recipient organ. Although ADSC-therapy is still in its infancy, the potential benefits of ADSCs are far reaching.
Insights
Adipose-derived stem cells (ADSCs) offer a promising alternative for diabetes treatment by differentiating into insulin-producing cells. ADSCs also enhance pancreatic islet transplantation success through improved vascularization and reduced inflammation.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Stem Cell Biology
Background:
- Diabetes mellitus affects millions globally, with current treatments limited by organ availability.
- Existing therapies like insulin injections and islet transplantation face challenges such as organ scarcity and immune rejection.
- Stem cell-based therapies offer a potential alternative for beta cell replacement.
Purpose of the Study:
- To explore the potential of adipose-derived stem cells (ADSCs) as an alternative source for insulin-producing cells.
- To investigate the capacity of ADSCs to support and improve pancreatic islet transplantation outcomes.
- To highlight the therapeutic advantages of ADSCs in managing diabetes.
Main Methods:
- Utilizing multipotent mesenchymal stem cells derived from adipose tissue.
- Differentiating adipose-derived stem cells (ADSCs) into insulin-producing cells.
- Evaluating ADSCs' potential for vasculogenesis, angiogenesis, and immunomodulation.
Main Results:
- Adipose-derived stem cells (ADSCs) can be obtained non-invasively and differentiate into insulin-producing cells.
- ADSCs promote vasculogenesis and angiogenesis, aiding donor islet engraftment.
- ADSCs exhibit anti-inflammatory and immunomodulatory properties beneficial for transplantation.
Conclusions:
- Adipose-derived stem cells (ADSCs) represent a viable and promising source for diabetes regenerative therapy.
- ADSC co-transplantation with pancreatic islets can significantly improve transplant success rates.
- Further research into ADSC-based therapies holds substantial potential for advancing diabetes treatment.
More Related Videos
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
10:50Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
Published on: April 7, 2023
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
iPS Cell Differentiation
Stem Cell Culture
Type II Diabetes II: Pathophysiology